EuroCareFinderExplore healthcare across Europe
← Back to EuroCareFinder

Condition

Phyllodes Tumor

Oncology

Overview

A type of connective tissue neoplasm typically arising from intralobular stroma of the breast. It is characterized by the rapid enlargement of an asymmetric firm mobile mass. Histologically, its leaf-like stromal clefts are lined by EPITHELIAL CELLS. Rare phyllodes tumor of the prostate is also known.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Phyllodes Tumor

Topic type
Condition
Category
Oncology
MeSH classification
C04.557.450.795.650

Preparing for an appointment about Phyllodes Tumor

If you are speaking with a healthcare professional about Phyllodes Tumor, it can help to prepare a few details in advance.

  • Write down your symptoms and when they started.
  • Bring details of any medicines, supplements or previous treatments.
  • Ask what tests or assessments may be needed.
  • Ask what treatment or management options may be suitable.
  • Ask when you should seek urgent medical help or follow-up care.

Finding care related to Phyllodes Tumor

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Explore clinics across Europe

Browse the wider EuroCareFinder healthcare network using the interactive map.

Clinics related to Phyllodes Tumor

No clinics are currently linked directly to Phyllodes Tumor on EuroCareFinder.

As more clinics add detailed services, related providers may appear here.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.

Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.